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Summary
Objective. The aim of this prospective study was to determine the
influence of anti-inflammatory drugs on the severity of odontogenic
cellulitis in patients admitted to our hospital emergency unit.
Study design. The study was made from April 30 to October 31
2006. The clinical and pharmacological data was prospectively
collected at admission, during hospitalization, and during systematic
follow-up. We first studied the whole population and then compared
the 2 groups: patients having received anti-inflammatory drugs
before admission or not.
Results. Two hundred and sixty-seven patients were included. The
only severity criterion significantly different between the 2 groups was
spreading of cervical lymphangitis (P = 0.028). None of the 4 studied
parameters was identified as a risk factor for spreading of cervical
lymphangitis in multivariate analysis: anti-inflammatory use
(OR = 5.99, 95%CI [0.71–50.88]), alcohol abuse (OR = 4.00, 95%CI
[0.66–24.12]), dental hygiene (OR = 1.53, 95%CI [0.36–6.56]), and
tobacco use (OR = 0.27, 95%CI [0.57–1.28]).
Discussion. The use of anti-inflammatory drugs during the initial
phase of an odontogenic infection was not related to the severity of
infection.
 2014 Elsevier Masson SAS. 
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Re´sume´
Objectif. Le but de cette e´tude prospective a e´te´ de de´finir
l’influence des anti-inflammatoires sur la gravite´ des cellulites
d’origine dentaire admise aux urgences de notre hoˆpital.
Mate´riel et me´thode. L’e´tude a porte´ sur les patients admis du 30
avril au 31 octobre 2006. Pour chacun d’entre eux, les renseigne-
ments cliniques et pharmacologiques ont e´te´ collige´s lors de leur
admission, puis au cours de l’hospitalisation ou lors d’une consul-
tation de controˆle syste´matique. Nous avons d’abord e´tudie´ la
population dans son ensemble, puis nous avons effectue´ une compa-
raison de deux groupes : ceux ayant rec¸u des anti-inflammatoires
avant l’admission et ceux n’en ayant pas rec¸u.
Re´sultats. Parmi les patients, 267 ont e´te´ inclus. Le seul crite`re de
gravite´ significativement diffe´rent entre les 2 groupes e´tait la diffusion
cervicale de type lymphangite (p = 0,028). Aucun des 4 parame`tres
e´tudie´s n’a e´te´ identifie´ comme facteur de risque pre´dictif d’une
diffusion cervicale de type lymphangite en analyse multivarie´e : utilisa-
tion d’anti-inflammatoires (OR = 5,99 ; IC95 % [0,71–50,88]), e´thy-
lisme (OR = 4,00 ; IC95 % [0,66–24,12]), hygie`ne dentaire (OR = 1,53 ;
IC95 % [0,36–6,56]), tabagisme (OR = 0,27 ; IC95 % [0,57–1,28]).
Discussion. La gravite´ des cellulites faciales ou cervico-faciales
d’origine dentaire n’est pas corre´le´e a` un traitement initial par anti-
inflammatoire.
 2014 Elsevier Masson SAS. 
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The mechanism of action of anti-inflammatory drugs includes
an inhibitory effect of immune defenses. This effect may
consequently promote the onset or the aggravation of infec-
tious processes normally controlled by an immune physiolo-
gical response. This potentially noxious role is often
mentioned for glucocorticosteroids, but also mentioned for
non-steroidal anti-inflammatory drugs (NSAID), as reported in
studies focusing on the potential of NSAID in the occurrence
of severe cutaneous and tissular complications in varicella
[1,2]. Many maxillo-facial surgeons observed in their daily
practice that anti-inflammatory drugs, particularly NSAID,
could promote the occurrence or the aggravation of dental
cellulitis [3–5]. They should be used cautiously in this context.
But, few authors have reported this clinical observation and
the role of anti-inflammatory drugs was thus never clearly
determined [5,6].
We conducted a prospective study for 6 months on a cohort of
patients having consulted in the stomatological and maxillo-
facial emergency unit of the Lille teaching hospital for cellu-
litis of dental origin. The main objective of our study, conduc-
ted conjointly by the maxillo-facial surgery unit and the
pharmacology department, was to determine the role of
anti-inflammatory drugs in the aggravation of facial or cer-
vico-facial cellulitis of dental origin.
Material and method
Inclusion criteria and data collection
We included, in this cohort study with prospective data
collection, consecutive patients admitted to the stomatolo-
gical and maxillo-facial emergency unit (EU) of the Lille
teaching hospital for facial or cervico-facial cellulitis of dental
origin, between April 30 and October 31, 2006. We excluded
patients for whom anti-inflammatory treatment prior to EU
admission could not be documented.
The diagnosis of facial or cervico-facial cellulitis of dental
origin was made on clinical and radiological evidence
(complete maxillo-facial examination with a panoramic
dental radiography) for all patients included. A cervico-
facial CT scan with injection of a contrast medium was
used if necessary, when there were clinical signs of cervical
extension. The main endpoint criterion was the severity of
dental cellulitis. The clinical data was collected prospecti-
vely by physicians of the surgical team at consultation in
the emergency unit. The pharmacology team checked medi-
cal treatments given before hospital admission, during a
systematic control consultation in the patient’s health
record.
The following parameters were documented for each included
patient:32 terrain: age, sex, tobacco abuse, alcohol abuse, dental
status (considered as good if the patient presented with less
than 2 caries), immunodepression or seropositivity for HIV;
 functional signs before hospitalization: dental pain,
swelling, fever, trismus, skin rash, fistulization, dyspnea,
dysphagia;
 characteristic clinical signs of infection: clinical signs,
dental portal of entry, localization, extension;
 the drug treatment received before hospitalization:
antalgics, antibiotics, mouthwash, anti-inflammatory drugs
(glucocorticosteroids, aspirin at anti-inflammatory dosage,
NSAID);
 the type of management: exclusively medical treatment,
surgical treatment, hyperbaric oxygen therapy;
 the duration of hospitalization.
Statistical analysis
We first studied the population globally, then compared the 2
groups: patients having received anti-inflammatory drugs
before admission (AI) and those not having received any
(non-AI). Patients having received at least one dose of anti-
inflammatory drugs were classified in the group AI. We then
compared the 4 groups depending on whether the patient AI
or non-AI had received antibiotics (ATB) or not (non-ATB)
before admission. Patients having received at least one dose
of antibiotics were classified in the group ATB.
The statistical analyses were made using the x2 test and
Fisher’s test for qualitative variables, and Levene and Stu-
dent’s tests and odds-ratio for quantitative variables. We used
logistic regression for significantly different variables in the
univariate analysis. The data base was built and analyzed with
the SPSS software (SPSS Inc., Chicago, IL, United States). The
threshold of significance was set at P < 0.05.Results
Two hundred and seventy-two consecutive patients were
admitted to the stomatological and maxillo-facial emergency
unit at the Lille teaching hospital, for facial or cervico-facial
cellulitis of dental origin, between April 30 and October 31,
2006. Each patient was given a standardized interview and
specific care at admission. Two hundred and sixty-seven
patients were included according to previously mentioned
criteria (fig. 1).
Population data (n = 267)
The mean age of patients was 31.3  13 years and 84.9% of
them were less than 45 years of age. The male sex was
predominant with a sex ratio of 1.17. Among the patients,
163 (62.7%) were smokers, 31 (12.1%) were alcohol abusers. The
dental status was considered as good for 156 patients (58.9%).
9 patients (3.5%) were immunodepressed or HIV-positive. The
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Figure 1. Flow-chart of the population distribution according to the intake
of anti-inflammatory drugs before admission.
Table I
Characteristics of cellulitis at admission to the emergency unit
for all patients (n = 267).
n %
Symptoms
Pain 258 97.4
Swelling 246 92.1
Rash 87 33.3
Trismus 55 21.1
Dysphagia 30 11.5
Fever 27 10.3
Fistulization 6 2.3
Dyspnea 2 0.8
Cause
Caries/pulp disease 207 83.1
Periodontal disease 29 11.6
Dental care 25 10.0
Dental avulsion 7 2.8
Other 14 5.6
Localization
Mandibular vestibular 146 55.5
Maxillary vestibular 99 37.5
Mandibular lingual supra mylohyoid 15 5.7
Mandibular lingual sub mylohyoid 9 3.4
Maxillary palatine 5 1.9
Extension
Cervical extension 15 5.6
Cervical swelling 11 4.2
Cervical lymphangitis 9 3.4
Temporal extension 2 0.8
Temporal swelling 2 0.8
Temporal lymphangitis 0 0
Mediastinal extension 0 0
Table II
Characteristic of sub-populations having received anti-
inflammatory drugs (AI; n = 141) or not (non-AI; n = 126) before
admission to the emergency unit.
Criteria AI Non AI P
Mean age in years
(standard deviation)
30 (12.1) 32.6 (14.1) 0.105
Sex
Male n (%) 77 (54.6) 67 (53.2) 0.861
Female n (%) 64 (45.4) 59 (46.8)
Dental status
Good n (%) 81 (57.9) 75 (60) 0.723
Bad n (%) 59 (42.1) 50 (40)
Tobacco abuse n (%) 82 (59.8) 81 (65.8) 0.318
Alcohol abuse n (%) 15 (11) 16 (13.2) 0.590
Immunodepression
(HIV) n (%)
6 (4.4) 3 (2.5) 0.507symptoms were variable before admission to the emergency
unit: dental pain for 6.5 days IC 95% [4.69–8.41], swelling for
3.3 days IC 95% [2.51–4.17], and fever for 0.5 days IC 95%
[0.3–0.7]. The data concerning treatment before hospitaliza-
tion could be collected for only 267 patients. One hundred and
forty-two (54.0%) of these patients had been given antibio-
tics, 190 (72.0%) antalgics, 141 (52.8%) anti-inflammatory
drugs, 167 (63.5%) mouthwash, and 16 (6%) had not received
any treatment. The clinical characteristics of cellulitis at
admission are listed in (table I). The origin of the infection
was dental caries with pulp necrosis for 207 patients (83.1%), a
periodontal disease for 29 patients (11.6%), dental care for 25
patients (10.0%), and dental extraction for 7 patients (2.8%).
Another cause was identified for 14 patients (5.6%). Ninety-
three patients (34.8%) were given treatment medical exclu-
sively, and 174 patients (65.2%) surgical treatment. One
hundred and fifty-five (58.1%) of the 267 patients, were
hospitalized for a mean stay of 5.8  3.7 days. Four patients
(1.5%) with severe presentations required of hyperbaric oxy-
gen therapy while hospitalized in the ICU. There was no death
or mediastinal infectious complication in our study popula-
tion.
Comparison of the 2 patient groups (AI and non-AI)
We then compared patients having received anti-inflamma-
tory drugs before their admission to the emergency unit (AI,
n = 141) and those not having taken any (non-AI, n = 126).
These 2 populations were demographically homogeneous
and similar (table II). Five percent of AI patients had received
glucocorticosteroids, 11.3% aspirin (> 3 g/d), and 91.5% NSAID
(frequently ibuprofen). Eleven patients (7.8%) had received 2
different types of anti-inflammatory drugs.
There was no significant difference between the 2 groups (AI
and non-AI) concerning the initial cause of infection, with
respectively, 82.1% and 84.4% due to dental caries with pulp33
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Table III
Comparison of AI patients (n = 141) with non-AIp atients (n = 126).
Al Non Al P
Symptoms at admission
Rash n (%) 46 (33.1) 41 (33.6) 0.857
Trismus n (%) 32 (23) 23 (18.8) 0.410
Dysphagia n (%) 18 (12.9) 12 (9.8) 0.405
Fever n (%) 13 (9.2) 14 (11.5) 0.434
Mean duration of fever (standard deviation) 2.4 (1–20) 1.8 (1–8) 0.336
Fistulization n (%) 3 (2.2) 3 (2.5) 1.000
Dyspnea n (%) 2 (1.4) 0 (0) 0.500
Localization
Mandibular vestibular n (%) 74 (52.9) 70 (56.9) 0.628
Maxillary vestibular n (%) 52 (37.1) 45 (36.3) 0.666
Mandibular lingual supra mylohyoid n (%) 7 (5) 8 (6.5) 0.611
Mandibular lingual sub mylohyoid n (%) 4 (2.9) 5 (4.1) 0.738
Maxillary palatine n (%) 3 (2.1) 2 (1.6) 1.000
Treatment before admission
Antibiotics n (%) 88 (62.4) 54 (42.8) 0.001
Extension
Cervical n (%) 11 (7.9) 4 (3.2) 0.105
Swelling n (%) 7 (5) 4 (3.2) 0.472
Lymphangitis n (%) 8 (5.7) 1 (0.8) 0.028
Temporal n (%) 1 (0.7) 1 (0.8) 1.000
Treatment after admission
Surgery n (%) 93 (66.4) 81 (64.3) 0.749
Hyperbaric oxygen therapy n (%) 3 (2.1) 1 (0.8) 0.624
Hospitalization
Hospitalization n (%) 83 (58.9) 73 (59.3) 0.563
Mean duration of hospitalization in
days (standard deviation)
5.6 (2.5) 5.9 (4.7) 0.563
Table IV
Predictive risk factors for cervical extension such as
lymphangitis.
Odds-ratio
Anti-inflammatory intake 5.993 IC95% [0.71–50.88]
Dental status 1.531 IC95% [0.36–6.56]
Ongoing tobacco abuse 0.271 IC95% [0.57–1.28]
Alcohol abuse 3.997 IC95% [0.66–24.12]necrosis, 13.4% and 9.6% due to a periodontal disease, 11.2%
and 8.7% due to dental care, 2.2% and 3.5% due to dental
avulsion, and 4.5% and 7% due to another cause. Seventeen
(6.4%) cases of diffuse cellulitis were observed among which
15 cases of diffuse cervical cellulitis and 2 cases of diffuse
temporal cellulitis. Five cases of diffuse cervical cellulitis
presented as cervical swelling associated with lymphangitis.
Eighty-eight AI patients (62.4%) and 54 non-AI patients
(42.8%) (P = 0.001) had been given antibiotics before their
hospital admission.
There was no significant difference between the 2 groups, at
admission, in the various severity criteria defined initially,
except for diffuse cervical cellulitis such as lymphangitis
(P = 0.028). The comparative data for AI and non-AI patients
is presented in (table III).
None of the studied parameters was identified as a predictive
risk factor for diffuse cervical cellulitis such as lymphangitis, in
the multivariate analysis (table IV): use of anti-inflammatory
drugs (OR = 5.99; IC 95% [0.71–50.88]), alcohol abuse
(OR = 4.00; IC 95% [0.66–24.12]), dental status (OR = 1.53; IC3495% [0.36–6.56]), tobacco abuse (OR = 0.27; IC 95%
[0.57–1.28]).
Comparison of 4 patient groups (non-AI/non-ATB,
AI/non-ATB, non-AI-ATB, and AI/ATB)
The comparison of AI and non-AI patients allowed observing a
significantly greater antibiotic consumption in AI patients. We
then compared 4 groups for AI or non-AI patients having
received antibiotics (ATB) or not (non-ATB) before admission.
The 4 groups, non-AI/non-ATB, AI/non-ATB, non-AI-ATB, and
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significant difference was observed when comparing the 4
groups for all studied criteria.
Discussion
This 6-month prospective mono-centric study of 267 patients
proved that anti-inflammatory drug intake was not statisti-
cally correlated with the severity of cellulitis of dental origin.
Anti-inflammatory drugs could theoretically increase the
severity and the extension of dental cellulitis, because of
their mechanisms of action. Most stomatologists and maxi-
llo-facial surgeons recommend using anti-inflammatory
drugs cautiously in this case, in agreement with reported
cases [3,4]. We did not want to question this cautious attitude
but the results of our study did not demonstrate any aggra-
vating action of anti-inflammatory drugs for cellulitis of
dental origin. Our comparative analysis revealed a significant
difference between AI and non-AI patients for diffuse cervical
cellulitis as lymphangitis, and despite antibiotic treatment.
Nevertheless, the multivariate analysis did not confirm this
result. Furthermore, when we considered diffuse cellulitis
globally (temporal and cervical), the difference between the
2 populations was no longer significant. The other studied
severity criteria were not significantly different in the 2
groups. Severe cellulitis with dyspnea having required hyper-
baric oxygen therapy was observed only in patients having
received anti-inflammatory treatment. Only 1 patient had not
received any anti-inflammatory drugs and was treated with
hyperbaric oxygen therapy, but he did not present with
dyspnea. But this relationship was not demonstrated in a
significant way. We found significantly more patients having
received antibiotic therapy before admission to the emer-
gency unit in the group of AI patients. This was probably due
to the frequent association of antibiotic therapy with anti-
inflammatory intake when prescribed by a physician. The
study of non-AI/non-ATB, AI/non-ATB, non-AI/ATB, and AI/
ATB groups did not allow demonstrating any significant
difference for all studied criteria, correlating with previous
results. More patients were included in our study than in most
published series [4,7–9]; this allowed us to analyze the contri-
bution of anti-inflammatory drugs to the severity of facial and
cervico-facial cellulitis of dental origin, by limiting the lack of
statistical power. But our study method did not allow study-
ing the action of anti-inflammatory drugs in the genesis of
cellulitis of dental origin. A comparative study of patients
exposed/not exposed to anti-inflammatory drugs should be
conducted to answer this question, in patients presenting
with dental pain and non-dental cellulitis. Our study results
also confirm that dental cellulitis is observed more frequently
in young male patients [7,9]. Most of our patients had a good
dental status. We did not study the socio-economic aspects
but we noted that a satisfactory dental status did not prevent
the occurrence of maxillo-facial infection. On the other hand,we noted a high rate of smokers (62.9%) compared to the
national French average (29.1% in the 15 to 75 year range in
2010) [10]. The role of tobacco in mouth infections is difficult
to define, due to the little and divergent published data
[10–12].
The most frequent symptoms in our study (pain, swelling,
rash) confirmed the inflammatory aspect of this disease and
correlated with reported symptoms [13,14]. The delay before
consultation ranged from 1 day to several months, and there
was a great variability of tolerance to pain in patients.
Nevertheless, the onset of swelling or fever usually made
patients consult rapidly. The most frequent cause of cervico-
facial cellulitis was caries with pulp necrosis [13] (affecting
more frequently molars [4,13]) and this was confirmed by our
results. Furthermore, the positioning of anatomic structures
could be related to the extension of cellulitis. Our results
support this hypothesis since 17 of our observed cases of
diffuse cellulitis, most frequently cervical (88.2%), had for
origin mandibular cellulitis. Cellulitis with secondary exten-
sion usually has a better prognosis than initial diffuse cellu-
litis [13], which could explain there none of our patients died.
This large cohort of patients and the low quantity of missing
data during 6 months allowed us to downrate the role of anti-
inflammatory drugs in the aggravation of dental cellulitis,
despite our study limitations and bias.
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